Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ-100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council
Vaccine and Infectious Disease Institute researchers co-author study on vaccine with potential to prevent the most common virus transmitted by a pregnant woman to her unborn child
March 23, 2009
A new vaccine that has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection was detailed in a study published in the March 19 edition of the New England Journal of Medicine. Dr. Larry Corey, co-director of the Hutchinson Center’s Vaccine and Infectious Disease Institute, and Dr. Meei-li Huang, of VIDI and a research scientist in the Virology Division at the University of Washington and an affiliate member in VIDI, were co-authors of the paper with colleagues at the University of Alabama at Birmingham, who led the study.